Year in Review: Opyl (ASX:OPL) with CEO, Michelle Gallaher

Michelle Gallaher, CEO at Opyl, took a look back on the company’s achievements in 2022 on Stockhead TV.

“We solve two problems, recruiting participants to clinical trials and designing better clinical trials,” said Michelle Gallaher.

“We’ve got two platforms. Opin AI recruits patients into clinical trials and it’s a global platform recruiting patients anywhere in the world, and TrialKey which is a software that designs clinical trial protocols,”

View the video on Stockhead: https://stockhead.com.au/stockhead-tv/year-in-review-opyl-asxopl-with-ceo-michelle-gallaher/